2006
DOI: 10.1016/j.fertnstert.2006.02.110
|View full text |Cite
|
Sign up to set email alerts
|

Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
54
0
4

Year Published

2009
2009
2016
2016

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 59 publications
(60 citation statements)
references
References 23 publications
2
54
0
4
Order By: Relevance
“…A comparable trend which didn't achieve statistical significance, was also noted in a similar trial in poor responders [22]. Some other previous studies reported a significant decrease in total dosage and duration of rFSH treatment in administration of rFSH supplemented or substituted by low dose hCG in a GnRH antagonist protocol [18,19,35,47].…”
Section: Variablementioning
confidence: 53%
See 2 more Smart Citations
“…A comparable trend which didn't achieve statistical significance, was also noted in a similar trial in poor responders [22]. Some other previous studies reported a significant decrease in total dosage and duration of rFSH treatment in administration of rFSH supplemented or substituted by low dose hCG in a GnRH antagonist protocol [18,19,35,47].…”
Section: Variablementioning
confidence: 53%
“…However, several other studies have shown better outcomes with additional LH in poor responders when GnRH-a short or long protocols were applied [40][41][42] whereas in the study of Bjercke et al and Hompes et al [43,44] in normal responders, the clinical outcomes were similar between rFSH and hMG groups. Some other trials demonstrated favorable treatment outcomes in an antagonist protocol in patients who received low dose hCG [18,45].…”
Section: Variablementioning
confidence: 99%
See 1 more Smart Citation
“…Both groups were stimulated with conventional antagonist protocols [21], briefly patients were started on day 3 with r-FSH (Gonal-F, Serono Labs.) and monitored with serial transvaginal ultrasounds to monitor and control follicular growth and endometrial thickness.…”
Section: Thismentioning
confidence: 99%
“…Multiple permutations of FSH and LH administration during the mid-and late follicular phases have been investigated with varying degrees of success in obtaining oocytes with embryonic developmental competence and efficiency of establishing pregnancies [16][17][18][19][20]. Several studies have demonstrated that administration of LH activity alone or combined with FSH can exert significant actions on folliculogenesis [10,21]. It is hypothesized that LH activity at this phase, enhances development of large pre-ovulatory follicles, ultimately giving rise to oocytes with increased embryonic developmental competence.…”
Section: Introductionmentioning
confidence: 99%